Publications and presentations

AVEO Oncology allows you to access a number of published papers and presentations outlining our clinical data that were given at premier conferences and symposia around the world.

June 7, 2011
PresentationTivozanib

ASCO 2011: Results From a Phase 1 Trial of Tivozanib (AV-951) Combined With Temsirolimus Therapy in Patients With Renal Cell Carcinoma

February 12, 2011
PublicationTivozanib

Development of second-generation VEGFR tyrosine kinase inhibitors: Current status

Authors: Pankaj Bhargava, Murray O. Robinson. Click here for link to article.

November 19, 2010
PresentationTivozanib

EORTC-NCI-AACR 2010: Tivozanib Biomarker Identifies Tumor-infiltrating Myeloid Cells Contributing to Tivozanib Resistance in Both Preclinical Models and Human Renal Cell Carcinoma

October 1, 2010
PresentationTivozanib

IKCS 2010: Effect of Hypertension, Nephrectomy, and Prior Treatment on the Efficacy of Tivozanib (AV-951) in a Phase 2 Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma

October 1, 2010
PresentationTivozanib

IKCS 2010: Activity of Tivozanib (AV-951) in Patients With Different Histologic Subtypes of Renal Cell Carcinoma

June 7, 2010
PresentationTivozanib

ASCO 2010: Activity of Tivozanib (AV-951) in Patients With Renal Cell Carcinoma (RCC): Subgroup Analysis From a Phase 2 Randomized Discontinuation Trial (RDT)

1 … 9 10 11 12

Looking for medical information? Contact our Medical Information Team at

AVEOmedicalinformation@aveooncology.com.